Novavax has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 2.2331, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Novavax will likely underperform. Novavax right now secures a risk of 6.42%. Please verify Novavax jensen alpha and semi variance to decide if Novavax will be following its current price movements.
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Novavax are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Novavax may actually be approaching a critical reversion point that can send shares even higher in October 2023. ...more
Last Split Factor
Last Split Date
|Entry to Agreement|
|130 per shot COVID vaccines Manufacturers warned against pri...|
|Why Novavax Stock Is Trading Higher Today|
|Major Covid Vaccine Stocks Rise as Sensitization Efforts Set...|
|Are These 2 Companies Next for Short Squeezes|
|COVID is evolving quickly in white-tailed deer, study finds|
|Should You Buy Novavaxs Stock Before the FDA Approves Its Ne...|
|Coronavirus Cases Are on the Rise Should You Buy Vaccine Sto...|
|This Down-on-Its-Luck Biotech Could Surge 150, Wall Street S...|
|Novavax Stock Drops 13 percent on Pending FDA Authorization ...|
|Does This Message From Moderna Mean Bad News for Novavax - T...|
|Begin Period Cash Flow||1.5 B|
Novavax Relative Risk vs. Return LandscapeIf you would invest 753.00 in Novavax on June 28, 2023 and sell it today you would lose (22.00) from holding Novavax or give up 2.92% of portfolio value over 90 days. Novavax is currently generating 0.1429% in daily expected returns and assumes 6.418% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than Novavax, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Given the investment horizon of 90 days Novavax is expected to generate 10.64 times more return on investment than the market. However, the company is 10.64 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.0 per unit of risk.
Novavax Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novavax's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Novavax, and traders can use it to determine the average amount a Novavax's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Novavax Fundamentals Growth
Novavax Stock prices reflect investors' perceptions of the future prospects and financial health of Novavax, and Novavax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Novavax Stock performance.
About Novavax Performance
Things to note about Novavax performance evaluationChecking the ongoing alerts about Novavax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Novavax help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions. Evaluating Novavax's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Novavax's stock performance include:
- Analyzing Novavax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Novavax's stock is overvalued or undervalued compared to its peers.
- Examining Novavax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Novavax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Novavax's management team can help you assess the company's leadership.
- Pay attention to analyst opinions and ratings of Novavax's stock. These opinions can provide insight into Novavax's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide. Note that the Novavax information on this page should be used as a complementary analysis to other Novavax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Novavax Stock analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
Is Novavax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.